0IL8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - FibroGen Inc

Watchlist Manager

Watchlist

Price: 7.2972 USD -5.23% Market Closed

Market Cap: $29.6m

	FibroGen Inc LSE:0IL8	US
	Macquarie Group Ltd F:4M42	AU
	Helvetia Holding AG F:HVXA	CH

Profitability Summary

FibroGen Inc's profitability score is 24/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

346%

Strong 3Y Average Gross Margin

113%

Gross Margin is Increasing

86% > 346%

Negative Operating Margin

-1 477%

Negative 3Y Average Operating Margin

-362%

Declining Operating Margin

-248% > -1 477%

Exceptional Net Margin

2 599%

Strong 3Y Average Net Margin

107%

Net Margin is Increasing

-247% > 2 599%

Negative Free Cash Flow Margin

-206%

Negative 3Y Average Free Cash Flow Margin

-229%

Free Cash Flow Margin is Increasing

-245% > -206%

Negative ROE

-165%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-124%

Declining ROIC

-168% > -177%

View All

Hide

Collapse

24 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.